Invention Grant
- Patent Title: Anti-Tim-3 antibodies for combination with anti-PD-1 antibodies
-
Application No.: US16346922Application Date: 2017-12-04
-
Publication No.: US11352424B2Publication Date: 2022-06-07
- Inventor: Yiwen Li , Yi Zhang
- Applicant: Eli Lilly and Company , Innovent Biologies (Suzhou) Co. Ltd.
- Applicant Address: US IN Indianapolis; CN Jiangsu
- Assignee: Eli Lilly and Company,Innovent Biologies (Suzhou) Co. Ltd.
- Current Assignee: Eli Lilly and Company,Innovent Biologies (Suzhou) Co. Ltd.
- Current Assignee Address: US IN Indianapolis; CN Jiangsu
- Agent Grant Reed
- International Application: PCT/US2017/064480 WO 20171204
- International Announcement: WO2018/106588 WO 20180604
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; A61N5/10 ; A61K39/00
Abstract:
The present invention relates to antibodies that bind human T-cell immunoglobulin- and mucin-domain-containing protein-3 (Tim-3), and may be useful for treating solid and hematological tumors in combination with anti-human PD-1 antibodies, chemotherapy, and ionizing radiation.
Public/Granted literature
- US20190276534A1 ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES Public/Granted day:2019-09-12
Information query
